All filters
Slidesets
Use of plasma PRO-C3, PRO-C5, and PRO-C6 for the diagnosis and follow-up of fibrosis stage in patients with nonalcoholic fatty liver disease (NAFLD)- iana Leeming
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Neoepitope fragments of extracellular matrix as markers of fibrosis in chronic liver disease: Insights into clinical and preclinical utilization for unfolding disease pathogenesis - Diana Leeming, PhD
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Feasibility of Using Deep-learning-based Techniques for Liver Couinaud Segmentation and Proton Density Fat Fraction (PDFF) Estimation- Hashem Almahmoud
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Repeatability and Reproducibility of Multiparametric Magnetic Resonance Imaging of the Liver- Andrea Dennis
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
FDA perspective on parallel review (Not available)- Rochelle Fink, MD, JD
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Opening lecture: A pathologist, a radiologist and a hepatologist walked into a bar- Brent Neuschwander-Tetri, MD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Innovation in histological assessment of NASH- Pierre Bedossa, MD, PhD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
EU perspective- Elmer Schabel, MD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Session 2: Pathways to biomarker qualification and acceptance- Chris Leptak, MD, PhD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Collaboration in action - Foundation for the National Institutes of Health- Roberto Calle, MD, FACE, FACP
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Collaboration in action - Innovative Medicines Initiative- Quentin Anstee, BSc, MB BS, PhD, MRCP(UK), FRCP
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Circulating nucleic acids and combination panels- Sven Francque, MD, PhD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
MRI; what can it deliver- Claude Sirlin, MD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Role of genetic assessments- Quentin Anstee, BSc, MB BS, PhD, MRCP(UK), FRCP
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Hepatic proton density fat fraction correlates with histologic measures of steatosis and is responsive to change in those measures in a multi-center nonalcoholic steatohepatitis clinical trial- Michael Middleton
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
A meta-analysis on repeatability of magnetic resonance elastography of liver- Suraj Serai
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Transient elastography & other techniques- Raj Vuppalanchi, MBBS
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Breath tests- Shadab Siddiqui, MD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Principles of kinetic measures- Greg Everson, MD, FACP
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Novel multiparametric magnetic resonance elastography (MRE) protocol accurately predicts NAS score for NASH diagnosis- Alina Allen
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Big data vs. the individual liver - regulatory perspective- Robert Schuck, PharmD, PhD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Serum GP73 as a surrogate biomarker of significant liver fibrosis and cirrhosis in NAFLD- Fengmin Lu
Presented at:
International Workshop on NASH Biomarkers 2017